PCI Biotech to present poster at 4th Immunotherapy of cancer conference – Nasdaq
|
PCI Biotech to present poster at 4th Immunotherapy of cancer conference
Nasdaq Oslo, Norway, March 21, 2017PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present a poster of the fimaVacc technology at the 4th … |
